Published in Clin Exp Immunol on May 01, 1970
Cell-mediated immunity in acute and chronic hepatitis. J Clin Invest (1975) 1.63
Mechanisms of corticosteroid action on lymphocyte subpopulations. III. Differential effects of dexamethasone administration on subpopulations of effector cells mediating cellular cytotoxicity in man. Clin Exp Immunol (1978) 1.03
In vitro cytotoxicity by human lymphocytes from individuals immunized against histocompatibility antigens. II. Relation to HL-A incompatibility between effector and target cells. Clin Exp Immunol (1970) 0.78
SEPARATION OF VIABLE LYMPHOCYTES FROM HUMAN BLOOD. Lancet (1964) 8.91
Effect of actinomycin D on cellular nucleic acid synthesis and virus production. Science (1961) 8.48
One-way stimulation in mixed leukocyte cultures. Science (1966) 6.62
Lysis of homologous cells by sensitized lymphocytes in tissue culture. J Natl Cancer Inst (1961) 5.16
Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. 3. Analysis of mechanism. J Exp Med (1968) 3.88
EFFECT OF LYMPHOCYTE DEPLETION BY THORACIC DUCT FISTULA AND ADMINISTRATION OF ANTILYMPHOCYTIC SERUM ON THE SURVIVAL OF SKIN HOMOGRAFTS IN RATS. Nature (1963) 3.65
PHYTOHAEMAGGLUTININ-INDUCED CYTOTOXIC ACTION OF NORMAL LYMPHOID CELLS ON CELLS IN TISSUE CULTURE. Nature (1964) 3.59
Differential effects of human granulocytes and lymphocytes on human fibroblasts in vitro. Clin Exp Immunol (1968) 3.38
Cellular antibodies in kidney homotransplantation. J Immunol (1960) 3.32
In vitro studies of ulcerative colitis. II. Cytotoxic action of white blood cells from patients on human fetal colon cells. J Exp Med (1963) 2.95
HOMOGRAFT TARGET CELLS: SPECIFIC DESTRUCTION IN VITRO BY CONTACT INTERACTION WITH IMMUNE MACROPHAGES. Science (1964) 2.60
THE REACTION OF IMMUNOLOGICALLY ACTIVATED LYMPHOID CELLS AGAINST HOMOLOGOUS LYMPHOID CELLS AGAINST HOMOLOGOUS TARGET TISSUE CELLS IN VITRO. J Cell Physiol (1963) 2.46
INTERACTION OF IMMUNE LYMPHOCYTES IN VITRO WITH NORMAL AND NEOPLASTIC TISSUE CELLS. Folia Biol (Praha) (1964) 2.34
Lymphocyte cytotoxicity in vitro: activation and release of a cytotoxic factor. Nature (1968) 2.24
Cytotoxic effect of lymphocyte-antigen interaction in delayed hypersensitivity. Science (1967) 2.11
ANTAGONISTIC EFFECTS OF HUMORAL ISOANTIBODIES ON THE IN VITRO CYTOTOXICITY OF IMMUNE LYMPHOID CELLS. J Exp Med (1965) 2.11
Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. I. Characterization of the phenomenon. J Exp Med (1968) 1.98
Cytotoxicity of human lymphocytes: antagonism between inducing processes. Nature (1968) 1.76
Non-specific induction of cytotoxicity in normal human lymphocytes in vitro: studies of mechanism and specificity of the reaction. Clin Exp Immunol (1969) 1.53
Destruction of human cells in tissue culture by lymphocytes from patients with systemic lupus erythematosus. Lancet (1966) 1.43
EFFECT OF MONONUCLEAR BLOOD CELLS FROM MULTIPLE SCLEROSIS PATIENTS ON NEUROGLIA IN TISSUE CULTURE. J Neuropathol Exp Neurol (1964) 1.23
STUDIES ON MONONUCLEAR CELLS OBTAINED FROM SYNOVIAL FLUID OF PATIENTS WITH DIFFERENT TYPES OF ARTHRITIS. CYTOTOXIC EFFECT ON TISSUE-CULTURED HUMAN FIBROBLASTS. Acta Pathol Microbiol Scand (1964) 1.19
The reaction of blood lymphocytes from patients with rheumatoid arthritis against human connective tissue cells in vitro. Clin Exp Immunol (1968) 1.06
Studies of anti-lymphocyte globulins made from thoracic duct lymphocytes. Transplant Proc (1969) 1.02
In vitro cytotoxicity by human lymphocytes from individuals immunized against histocompatibility antigens. II. Relation to HL-A incompatibility between effector and target cells. Clin Exp Immunol (1970) 0.78
Differential effects of human granulocytes and lymphocytes on human fibroblasts in vitro. Clin Exp Immunol (1968) 3.38
HLA-matching and pretransplant blood transfusions in cadaveric renal transplantation--a changing picture with cyclosporin. Lancet (1986) 2.08
Cytotoxicity of human lymphocytes: antagonism between inducing processes. Nature (1968) 1.76
Steroid diabetes--a sign of overtreatment with steroids in the renal graft recipient? Scand J Urol Nephrol Suppl (1980) 1.63
Non-specific induction of cytotoxicity in normal human lymphocytes in vitro: studies of mechanism and specificity of the reaction. Clin Exp Immunol (1969) 1.53
Subclass reactivity to Epstein-Barr virus capsid antigen in primary and reactivated EBV infections. J Med Virol (1987) 1.52
Drug metabolism in human liver in vitro: establishment of a human liver bank. Clin Pharmacol Ther (1980) 1.39
Reversible renal failure during treatment with captopril. Br Med J (1979) 1.35
Correction of hyperbilirubinemia in the glucuronyltransferase-deficient rat by intraportal hepatocyte transplantation. Transplant Proc (1977) 1.35
Effect of neuraminidase on the stimulatory capacity of cells in human mixed lymphocyte cultures. Clin Exp Immunol (1971) 1.32
Deterioration in glucose metabolism in pancreatic transplant recipients given cyclosporin. Lancet (1983) 1.26
Intravenous foscarnet for the treatment of severe cytomegalovirus infection in allograft recipients. Scand J Infect Dis (1985) 1.25
Drainage of thoracic duct lymph in renal transplant patients. Transplantation (1976) 1.21
Experience with human liver grafts obtained after donor cardiac standstill. Transplant Proc (1987) 1.18
Prevention of kidney graft diabetic nephropathy by pancreas transplantation in man. Diabetes (1985) 1.13
Successful outcome of segmental human pancreatic transplantation with enteric exocrine diversion after modifications in technique. Lancet (1982) 1.12
Ischemic heart disease--major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation (1995) 1.11
Cytomegalovirus infection associated with and preceding chronic graft-versus-host disease. Transplantation (1984) 1.08
Induction and suppression of the cytotoxic activity of human lymphocytes in vitro by heterologous anti-lymphocyte serum. Clin Exp Immunol (1969) 1.06
Acyclovir prophylaxis in bone marrow transplant recipients. Scand J Infect Dis Suppl (1985) 1.05
Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase. Surgery (1971) 0.98
Kidney donors don't regret: follow-up of 370 donors in Stockholm since 1964. Transplantation (2000) 0.94
Effect of neuraminidase on growth of a 3-methylcholanthrene-induced fibrosarcoma in normal and immunosuppressed syngeneic mice. J Natl Cancer Inst (1971) 0.94
A technique for rapid harvesting of cadaveric renal and pancreatic grafts after circulatory arrest. Br J Surg (1976) 0.92
Inhibition of acetylcholine release in guinea pig ileum by adenosine. Acta Physiol Scand (1978) 0.91
Pre- and postjunctional effects of prostaglandin E2, prostaglandin synthetase inhibitors and atropine on cholinergic neurotransmission in guinea pig ileum and bovine iris. Acta Physiol Scand (1980) 0.91
Long-term acyclovir prophylaxis in bone marrow transplant recipients and lymphocyte proliferation responses to herpes virus antigens in vitro. Bone Marrow Transplant (1986) 0.91
Rejection of isolated pancreatic allografts in patients with with diabetes. Surg Gynecol Obstet (1976) 0.91
Segmental pancreatic transplantation with duct ligation or drainage to a jejunal Roux-en-Y loop in nonuremic diabetic patients. Diabetes (1980) 0.90
Markedly elevated serum IgE levels following allogeneic and syngeneic bone marrow transplantation. Blood (1983) 0.90
The role of parathyroidectomy in the treatment of secondary hyperparathyroidism before and after renal transplantation. Scand J Urol Nephrol Suppl (1977) 0.88
Improved results in pancreatic transplantation by avoidance of nonimmunological graft failures. Transplantation (1987) 0.88
Selective decontamination of alimentary tract microbial flora in patients treated with bone marrow transplantation. A microbiological study. Scand J Infect Dis (1984) 0.86
Recurrent diabetic nephropathy in renal allografts placed in diabetic patients and protective effect of simultaneous pancreatic transplantation. Transplant Proc (1987) 0.86
Pancreatic transplantation with enteric exocrine diversion--the Stockholm experience. Transplant Proc (1987) 0.85
Relationship between acetylcholine and cholinesterase activity in the brain following an organophosphorus cholinesterase inhibitor. Biochem Pharmacol (1967) 0.85
Related donor kidney transplantation is the best form of treatment for uremia. Transplant Proc (1987) 0.85
Survival of isolated human islets of Langerhans maintained in tissue culture. J Clin Invest (1976) 0.84
Renal transplantation in insulin-treated diabetics. Transplant Proc (1979) 0.84
Role of MLC compatibility in intrafamilial kidney transplantation. Transplantation (1976) 0.83
Zinc and manganese contents of micro-dissected pancreatic islets of some rodents. A microchemical study in adult and newborn guinea pigs, rats, Chinese hamsters and spiny mice. Acta Endocrinol (Copenh) (1977) 0.83
Experience with nine segmental pancreatic transplantations in preuremic diabetic patients in Stockholm. Transplant Proc (1980) 0.83
Attempt at enzyme replacement by organ transplantation: renal transplantation in Gaucher disease. Transplant Proc (1979) 0.82
Fulminating anti-A autoimmune hemolysis with anuria in a renal transplant recipient: a therapeutic role of plasma exchange. Clin Nephrol (1981) 0.82
Progress in segmental pancreatic transplantation. World J Surg (1986) 0.81
Attempt at enzyme replacement in Gaucher disease by renal transplantation. Acta Paediatr Scand (1979) 0.81
Subcellular fractionation of cat submandibular gland: comparative studies on the distribution of acetylcholine and vasoactive intestinal polypeptide (VIP). Neuroscience (1981) 0.81
Pretransplant dialysis and blood transfusion--correlation with cadaveric kidney graft survival. Transplant Proc (1979) 0.81
Metabolic control at two months to 4.5 years after pancreatic transplantation, with special reference to the role of cyclosporine. Transplant Proc (1987) 0.80
Experience with a cooperative bone marrow transplantation program in Stockholm. Transplantation (1982) 0.80
Is cell-mediated immunity in the uremic patient affected by blood transfusion? Transplant Proc (1981) 0.80
Segmental pancreatic transplantation with enteric exocrine diversion. World J Surg (1984) 0.80
Subcutaneous arteriovenous fistulas for dialysis with special emphasis on vascular insufficiency. Scand J Urol Nephrol (1976) 0.80
Metallothionein in rabbit kidneys preserved for transplantation. Environ Health Perspect (1984) 0.80
Studies of the exocrine secretion of segmental pancreatic grafts with special reference to the diagnosis of rejection and to the penetration of drugs into the pancreatic juice. Transplant Proc (1987) 0.80
Hypersequestration of 51Cr-labelled erythrocytes as a criterion for splenectomy in regular hemodialysis patients. Clin Nephrol (1977) 0.79
Deterioration in glucose metabolism in pancreatic transplant recipients after conversion from azathioprine to cyclosporine. Transplant Proc (1984) 0.79
Secondary hyperparathyroidism and its sequelae in renal transplant recipients. Long term findings in a series of conservatively managed patients. Scand J Urol Nephrol Suppl (1977) 0.79
Listeria encephalitis in five renal transplant recipients. Acta Med Scand (1978) 0.79
Lead in umbilical cord blood correlated with the blood lead of the mother in areas with low, medium or high atmospheric pollution. Acta Paediatr Scand (1977) 0.79
Diagnosis of rejection in recipients of pancreatic grafts with enteric exocrine diversion by monitoring pancreatic juice cytology and amylase excretion. Transplant Proc (1987) 0.79
An in vitro test of the immunosuppressive activity of antilymphocyte serum. Transplantation (1970) 0.79
Diabetes mellitus--a more-common-than-believed complication of renal transplantation. Transplant Proc (1979) 0.78
Transplantation of fetal pancreatic microfragments via the portal vein to a diabetic patient. Diabetes (1980) 0.78
Plasma C-peptide and serum insulin antibodies in diabetic patients receiving pancreatic transplants. Diabetologia (1980) 0.78
In vitro cytotoxicity by human lymphocytes from individuals immunized against histocompatibility antigens. II. Relation to HL-A incompatibility between effector and target cells. Clin Exp Immunol (1970) 0.78
Cadaveric renal transplantation in patients of 60 years and above. Transplantation (1980) 0.78
Steroid diabetes after renal transplantation--a preliminary report. Scand J Urol Nephrol Suppl (1977) 0.77
[Kidney transplantation without chemical immunosuppression]. Nord Med (1970) 0.77
Influence of early cyclosporine dosage and plasma and whole blood levels on acute rejections in cadaveric renal allograft recipients. Transplant Proc (1988) 0.77
Structural and functional integrity of isolated human islets of langerhans maintained in tissue culture for 1-3 weeks. Transplant Proc (1977) 0.77
Microchemical assays of glutathione, zinc, cobalt and manganese in micro-dissected areas of the endocrine pancreas in the hagfish, Myxine glutinosa. Acta Endocrinol (Copenh) (1977) 0.76
Effect of physostigmine and atropine on acetylcholine turnover in mouse brain. Naunyn Schmiedebergs Arch Pharmacol (1979) 0.76
Recurrence of diabetic nephropathy in human renal allografts: preliminary report of a biopsy study. Transplant Proc (1984) 0.76
Atropine in mouse brain and plasma quantified by mass fragmentography. Acta Pharmacol Toxicol (Copenh) (1981) 0.76
Induction of DNA synthesis in lymphocytes from ALG-treated patients. Clin Exp Immunol (1970) 0.75
The significance of HLA-A, -B matching for the survival of cadaveric kidney transplants performed in Stockholm in 1970-78. Scand J Urol Nephrol Suppl (1980) 0.75
Attempts at transplantation of fetal pancreas to diabetic patients. Transplant Proc (1980) 0.75
Plasma C-peptide as an indicator of human pancreatic graft function. Acta Med Scand Suppl (1980) 0.75
[Bone marrow transplantation]. Lakartidningen (1978) 0.75
Successful treatment with prednisone and graft-versus-host disease in an allogeneic bone-marrow transplant recipient. Scand J Haematol (1979) 0.75
Dialysis and renal transplantation in end-stage diabetic nephropathy. A survey. Acta Med Scand Suppl (1980) 0.75
Attempt at enzyme replacement in Gaucher disease by renal transplantation. Birth Defects Orig Artic Ser (1980) 0.75
Cadaveric renal graft survival: the bearing of the number of blood transfusions and of dialysis treatment. Scand J Urol Nephrol Suppl (1980) 0.75
Angiography and scintigraphy of human pancreatic allografts. Acta Radiol Diagn (Stockh) (1978) 0.75
Pancreatic transplantation for diabetes mellitus. Ann Clin Res (1981) 0.75
[Bone marrow transplantation--an alternative treatment for aplastic anemia and leukemia]. Lakartidningen (1977) 0.75
Renal transplantation in polycystic renal disease--a joint Scandinavian report. Scand J Urol Nephrol Suppl (1980) 0.75
Plasma selenium in healthy man before and after nutratherapy. Int J Vitam Nutr Res (1997) 0.75
The significance of HLA-A and -B matching for cadaver-kidney survival in Stockholm 1970--1976. Scand J Urol Nephrol Suppl (1977) 0.75
Improved renal graft survival in transfused uremics. A result of a number of interacting factors. Transplantation (1980) 0.75
Further experience with antihuman lymphocyte globulin (Behring): no effect on cadaveric renal graft survival. Scand J Urol Nephrol (1981) 0.75
Segmental pancreatic transplantation with special reference to the use of ileal exocrine diversion and to the hemodynamics of the graft. Transplant Proc (1980) 0.75
The implications of HLA-DR match for the outcome of cadaveric renal transplantation. Scand J Urol Nephrol Suppl (1980) 0.75
Living related kidney donors: complications and long-term renal function. Transplantation (1978) 0.75
Assessment of pancreatic graft function. Transplant Proc (1980) 0.75
The effect of immunosuppressive therapy on the phagocytic and metabolic functions of the reticuloendothelial system in renal transplant recipients. Scand J Urol Nephrol Suppl (1980) 0.75
A controlled trial of antihuman lymphocyte globulin (Behring) in cadaveric renal transplantation: improvement in graft and patient survival at one year using a high-dose regimen. Scand J Urol Nephrol Suppl (1977) 0.75
Experience with pancreatic transplantation in Stockholm. Acta Med Scand Suppl (1980) 0.75
Analysis of the immunological effect of lymph drainage in organ transplant recipients. Scand J Urol Nephrol Suppl (1980) 0.75